Tuberculosis Monitor
Copyright © 2024 Taiwan Centers for Disease Control. All rights reserved.
SUMMARY
Global and Taiwan's TB Overview
  • Taiwan has a moderate-burden of TB, with TB incidence rate lower than South Korea, Singapore, but higher than United State and Japan.


Taiwan's Progress on Indicators for the WHO End TB Strategy and the 2023 UN High-Level Meeting is Superior to the Global Average.
End TB Strategy, 2025 milestones
"%" Reduction in the TB incidence rate
(compared with 2015)
12%
43%
2025 Milestones
50%
Global
Taiwan
"%" Reduction in the number of TB deaths
(compared with 2015)
29%
25%
2025 Milestones
75%
Global
Taiwan
UN high-level meeting on TB, targets
People diagnosed with TB who were initially tested with a WHO-recommended rapid test
54%
69%
2027 Target
100%
Global
Taiwan
TPT coverage: household contacts
25%
87%
2027 Target
90%
Global
Taiwan


Indicators for each country
2024 TB Incidence "%" change
2015 to 2024		 New & relapse cases new & relapse tested with
rapid diagnostics at diagnosis		 MDR/RR-TB Incidence New TB cases
with MDR/RR-TB		 people with TB
with known HIV(+) status		 TB case fatality ratio TB treatment coverage Treatment success rate for new
& relapse cases		 Treatment success rate for
MDR/RR-TB cases started on 2nd-line treatment		 "%" household contacts of
B+ TB cases on TPT
unit N per 105 % N per 105 % N per 105 % N % % % % % %
Taiwan 6,141 26 -43 6,352 27 69 89 0.4 1.2 24 0.4 5.7 94 70 74 87
Global 10,700,000 131 -12 8,300,000 102 54 390,000 4.8 3.2 413,500 6.2 12 78 88 71 25
China 696,000 49 -24 531,097 37 87 28,000 2 2.9 6,800 1.8 4 76 95 68 2
Australia 1,900 6.9 16 1,600 6 - 52 0.19 2.3 15 1.2 2.2 87 47 84 8
Japan 12,000 9.8 -44 10,100 8 - 410 0.33 2.8 29 4.6 12 83 67 29 8.3
Republic of Korea 18,000 35 -56 16,800 32 62 670 1.3 2.6 - - 8.6 94 79 74 20
Singapore 2,500 43 -5.3 2,200 38 92 53 0.9 2 17 0.78 1.1 89 74 39 16
Viet Nam 184,000 182 -8.4 106,400 105 62 94,000 9.3 4.2 2,400 2.8 7 58 89 71 9.1
Malaysia 34,000 96 -7.8 26,200 74 22 430 1.2 0.79 1,200 4.6 8.8 77 82 71 17
Philippines 724,000 625 14 544,900 470 74 28,000 24 2.3 2,800 0.76 5.6 75 84 76 11
India 2,700,000 187 -21 2,500,000 172 38 130,000 8.8 3.6 33,200 1.4 11 92 90 77 45
Indonesia 1,100,000 382 17 839,000 291 65 26,000 9.2 1.8 17,700 3 12 77 86 59 7.1
Thailand 104,000 146 -11 81,700 114 69 2,400 3.4 1.7 5,200 7.5 11 78 82 70 7.1
USA 11,000 3.2 -1.3 - - - 230 0.07 1.5 - - 5.8 - - - -
UK 6,700 9.7 -4 5900 8.6 42 140 0.2 1.9 86 1.6 3.8 89 86 82 22
South Africa 249,000 389 -61 183,700 287 56 14,000 209 3.6 86,000 7.1 23 74 71 63 15
TB Incidence
  • In 2024, there were 6,141 new cases of TB, resulting in an incidence rate of 26.2 cases per 100,000 populaton.
  • From 2005 to 2024, cumulative reduction of 62.7% in number of TB cases, and 63.9% in TB incidence rate.
The majority of TB cases were in individuals aged 65 or older, accounting for 64.4%。
The incidence rate increased with age.
AFS(+) cases accounted for 42.9% of all new cases, and Bac(+) cases accounted for 81.2% of all new cases.
TB incidence rate in the mountainous aboriginal regions was 66.0 per 100,000 population,
with Daren Township of Taitung county recording the highest incidence rate,
followed by Nanao township of Yilan county as the second highest.
TB Mortality
In 2024, there were 427 TB death, with a mortality rate of 1.8 deaths per 100,000 populaton.
From 2005 to 2024, cumulative reduction of 56.0% in number of TB deaths, and 58.1% in TB mortality rate.
Note:
Since 2019, Taiwan’s Ministry of Health and Welfare has adopted the European Union system (IRIS institute) for determining causes of death. Historical data predating 2019 requires conversion before it can be compared with data from 2019 onwards.


The majority of TB deaths were in individuals aged 65 or older, accounting for 86.4%.
The mortality rate increased with age.
TB mortality rate in the mountainous aboriginal regions was 5.0 per 100,000 population.
Drug-resistant TB
In 2024, there were 66 MDR-TB, 23 RR-TB (w/o MDR), 9 pre-XDR-TB and 0 XDR-TB.
Note:
  1. No. of registries includes Taiwan-born new and retreated TB cases.
  2. The RR-TB registry policy was initiated in 2017. RR-TB cases in 2017 included newly diagnosed and prevalent cases.


Note:This data is limited to Taiwan-born culture-confirmed new TB cases.
TB Classification and Site of Disease

In 2024, 6,141 new TB cases were diagnosed. Of these, 71.6% were bacteriologically confirmed pulmonary TB, 23.1% were clinically-diagnosed pulmonary TB and 5.3% had extrapulmonary TB.

Additionally, 211 relapse cases were diagnosed during the same year.
TB/HIV Comorbidity
Out of the 6,141 new TB cases in 2024, 24 were HIV-positive. Of these,
91.7% (22/24) were male, and 91.7% (22/24) were under the age of 65.
Foreign-born TB
In 2024, 804 foreign-born TB cases were diagnosed, mainly from Indonesia, Vietnam, and Philippines. The majority of cases involved foreign migrant workers, and were predominantly between 25 and 34 years old.
TB Treatment Outcomes
For new TB cases diagnosed in 2023, the TB treatment outcomes at 12 months:
70.0% had successful treatment, 23.5% died (either due to TB or other causes), 0.4% experienced treatment failure, 1.4% were lost to follow-up, 0.1% were transferred out, 4.6% remained non-evaluated.
Treatment success rate for new TB cases: 88.8% for TB aged 0-44, 80.1% for TB aged 45-64, and 63.1% for TB aged 65 or older.
For bacteriologically confirmed pulmonary TB new cases diagnosed in 2023, the TB treatment outcomes at 12 months:
64.5% were cured, 3.1% completed treatment, 26.8% died (either due to TB or other causes), 0.5% experienced treatment failure, 1.0% were lost to follow-up, 0.1% were transferred out, 4.1% remained non-evaluated.
Treatment success rate for bacteriologically confirmed pulmonary TB new cases: 88.7% for TB aged 0-44, 79.1% for TB aged 45-64, and 60.8% for TB aged 65 or older.
TOP